For the quarter ending 2026-03-31, FHTX has $222,167K in assets. $298,575K in debts. $87,663K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 87,663 | 80,876 | 89,334 | 72,572 |
| Marketable securities | 95,968 | 78,018 | 90,944 | 126,093 |
| Restricted cash | 1,250 | 1,250 | 1,250 | 1,250 |
| Prepaid expenses and other current assets | 3,183 | 3,091 | 2,589 | 3,927 |
| Total current assets | 188,064 | 163,235 | 184,117 | 203,842 |
| Property and equipment, net | 1,712 | 1,915 | 8,662 | 9,514 |
| Restricted cash | 2,000 | 2,000 | 2,000 | 2,000 |
| Other assets | 3 | 4 | 5 | 6 |
| Operating lease right-of-use assets | 30,388 | 30,949 | 10,178 | 10,874 |
| Total assets | 222,167 | 198,103 | 204,962 | 226,236 |
| Accounts payable | 3,317 | 4,266 | 3,212 | 3,322 |
| Accrued expenses and other current liabilities | 6,924 | 11,357 | 9,822 | 8,564 |
| Operating lease liabilities | 1,863 | 923 | 6,755 | 6,176 |
| Deferred revenue | 52,300 | 43,192 | 65,299 | 59,724 |
| Total current liabilities | 64,404 | 59,738 | 85,088 | 77,786 |
| Operating lease liabilities, net of current portion | 40,131 | 40,347 | 15,774 | 17,522 |
| Deferred revenue, net of current portion | 193,587 | 205,962 | 193,102 | 206,830 |
| Other liabilities | 453 | 556 | 656 | 757 |
| Total liabilities | 298,575 | 306,603 | 294,620 | 302,895 |
| Common stock, 0.0001 par value 175,000,000 shares authorized at march31, 2026 and december31, 2025 58,710,490 shares issued and outstanding at march31, 2026 and 56,657,329 shares issued and outstanding at december31, 2025 | 6 | 6 | 6 | 6 |
| Additional paid-in capital | 576,061 | 523,937 | 521,115 | 518,333 |
| Accumulated other comprehensive gain (loss) | -133 | 24 | 24 | -44 |
| Accumulated deficit | -652,342 | -632,467 | -610,803 | -594,954 |
| Total stockholders deficit | -76,408 | -108,500 | -89,658 | -76,659 |
| Total liabilities and stockholders deficit | 222,167 | 198,103 | 204,962 | 226,236 |
Foghorn Therapeutics Inc. (FHTX)
Foghorn Therapeutics Inc. (FHTX)